Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Nature Communications|June 21, 2020
Regular-triangle trimer and charge order preserving the Anderson condition in the pyrochlore structure of CsW2O6Yoshihiko Okamoto, Haruki Amano, Naoyuki Katayama, et al.
International Journal of Hematology|September 26, 2014
Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxabanTakumi Aota, Katsuki Naitoh, Hideo Wada, et al.
European Journal of Haematology|December 14, 2005
Molecular analysis of PDGFRalpha/beta genes in core binding factor leukemia with eosinophiliaFumihiko Monma, Kazuhiro Nishii, Felipe Lorenzo, et al.
Cell Reports|August 31, 2022
A bifurcation concept for B-lymphoid/plasmacytoid dendritic cells with largely fluctuating transcriptome dynamicsKeiki Nagaharu, Yasuhiro Kojima, Haruka Hirose, et al.
Cancer Immunology Research|May 20, 2016
Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer PatientsKohei Tada, Shigehisa Kitano, Hirokazu Shoji, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Absence of Jahn-Teller transition in the hexagonal Ba3CuSb2O9 single crystalNaoyuki Katayama, Kenta Kimura, Yibo Han, et al.
Nature Communications|October 19, 2018
Photo-induced semimetallic states realised in electron-hole coupled insulatorsKozo Okazaki, Yu Ogawa, Takeshi Suzuki, et al.
Vaccine|September 19, 2009
Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432Masatoshi Aoki, Shugo Ueda, Hiroyoshi Nishikawa, et al.
Cancer Immunology, Immunotherapy : CII|January 26, 2020
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumorsMikiya Ishihara, Yasutaka Tono, Yoshihiro Miyahara, et al.
Pancreas|January 20, 2016
Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoing Gemcitabine-Based ChemoradiotherapyReiko Yamada, Shugo Mizuno, Katsunori Uchida, et al.
Pageof 22